Cargando…
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancer
Checkpoint blockade immunotherapy transforms many types of cancer; however, in the field of metastatic colorectal cancer, checkpoint blockers are only effective in microsatellite-unstable tumors, which represent only a minority of patients. Microsatellite-stable tumors are thought to be immunoresist...
Autores principales: | Thibaudin, Marion, Ghiringhelli, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506430/ https://www.ncbi.nlm.nih.gov/pubmed/37727739 http://dx.doi.org/10.1080/2162402X.2023.2257098 |
Ejemplares similares
-
MAPK signaling regulates the efficacy of chemoimmunotherapy
por: Ghiringhelli, François
Publicado: (2022) -
Chemoimmunotherapy as long-term maintenance therapy for cancer
por: Egilmez, Nejat K., et al.
Publicado: (2012) -
Targeting coagulation to unlock antitumor immunity?
por: Galmiche, Antoine, et al.
Publicado: (2022) -
LPCAT2 controls chemoresistance in colorectal cancer
por: Cotte, Alexia Karen, et al.
Publicado: (2018) -
Immune ambivalence: The schizophrenic bleomycin
por: Mignot, Grégoire, et al.
Publicado: (2013)